Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity.

MLA

Dourdouna, Maria-Myrto, et al. “Evaluation of T Cell Responses with the QuantiFERON SARS-CoV-2 Assay in Individuals with 3 Doses of BNT162b2 Vaccine, SARS-CoV-2 Infection, or Hybrid Immunity.” Diagnostic Microbiology & Infectious Disease, vol. 106, no. 3, July 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.diagmicrobio.2023.115948.

APA

Dourdouna, M.-M., Tatsi, E.-B., Syriopoulou, V., & Michos, A. (2023). Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity. Diagnostic Microbiology & Infectious Disease, 106(3), N.PAG. https://doi.org/10.1016/j.diagmicrobio.2023.115948

Chicago

Dourdouna, Maria-Myrto, Elizabeth-Barbara Tatsi, Vasiliki Syriopoulou, and Athanasios Michos. 2023. “Evaluation of T Cell Responses with the QuantiFERON SARS-CoV-2 Assay in Individuals with 3 Doses of BNT162b2 Vaccine, SARS-CoV-2 Infection, or Hybrid Immunity.” Diagnostic Microbiology & Infectious Disease 106 (3): N.PAG. doi:10.1016/j.diagmicrobio.2023.115948.